Downstream gene activation of the receptor ALX by the agonist annexin A1.
暂无分享,去创建一个
Giuseppe Cirino | Derek Renshaw | F. D’Acquisto | M. Perretti | Trinidad Montero-Melendez | G. Cirino | Mauro Perretti | V. Brancaleone | J. Dalli | Trinidad Montero-Melendez | D. Renshaw | Jesmond Dalli | Fulvio D'Acquisto | Ahmad Kamal | Vincenzo Brancaleone | A. Kamal | T. Montero-Melendez
[1] T. Golub,et al. Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. , 2006, Cancer cell.
[2] M. Perretti,et al. Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. , 2006, Blood.
[3] S. Moss,et al. Annexins: linking Ca2+ signalling to membrane dynamics , 2005, Nature Reviews Molecular Cell Biology.
[4] U. V. von Andrian,et al. Fingolimod and sphingosine-1-phosphate--modifiers of lymphocyte migration. , 2006, The New England journal of medicine.
[5] J. Hoyt,et al. Tetracyclines and pulmonary inflammation. , 2007, Endocrine, metabolic & immune disorders drug targets.
[6] Adriano G. Rossi,et al. Inflammatory Resolution: new opportunities for drug discovery , 2004, Nature Reviews Drug Discovery.
[7] M. Perretti,et al. Modulation of Phagocytosis of Apoptotic Neutrophils by Supernatant from Dexamethasone-Treated Macrophages and Annexin-Derived Peptide Ac2–261 , 2005, The Journal of Immunology.
[8] J. Haycock,et al. Anti-microbial action of melanocortin peptides and identification of a novel X-Pro-d/l-Val sequence in Gram-positive and Gram-negative bacteria , 2008, Peptides.
[9] M. Paul-Clark,et al. The FASEB Journal express article 10.1096/fj.02-0239fje. Published online December 3, 2002. Aberrant inflammation and resistance to glucocorticoids in Annexin 1 –/ – Mouse , 2022 .
[10] J. Wallace,et al. Resolution of in flammation: state of the art, definitions and terms , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] M. Aurrand-Lions,et al. Expression and function of junctional adhesion molecule-C in human and experimental arthritis , 2007, Arthritis research & therapy.
[12] G. Zlabinger,et al. Sphingosine 1-phosphate phosphatase 2 is induced during inflammatory responses. , 2007, Cellular signalling.
[13] Caimin Xu,et al. Microarray analysis of differential gene expression in temporomandibular joint condylar cartilage after experimentally induced osteoarthritis. , 2005, Osteoarthritis and cartilage.
[14] F. D’Acquisto. On the adaptive nature of annexin-A1. , 2009, Current opinion in pharmacology.
[15] Marc Parmentier,et al. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family , 2009, Pharmacological Reviews.
[16] D. Gold,et al. Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1 , 2007, Cell Death and Differentiation.
[17] S. Marullo,et al. Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor , 2002, Nature Medicine.
[18] P. Hutchinson,et al. Inhibitory effect of annexin I on synovial inflammation in rat adjuvant arthritis. , 1999, Arthritis and rheumatism.
[19] Takao Shimizu,et al. The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo , 2006, Pharmacological Reviews.
[20] M. Perretti,et al. Annexin 1‐deficient neutrophils exhibit enhanced transmigration in vivo and increased responsiveness in vitro , 2005, Journal of leukocyte biology.
[21] G. Fantuzzi,et al. Histone Hyperacetylation Is Associated with Amelioration of Experimental Colitis in Mice1 , 2006, The Journal of Immunology.
[22] M. Perretti,et al. Annexin 1 and neutrophil apoptosis. , 2004, Biochemical Society transactions.
[23] M. Cybulsky,et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated , 2007, Nature Reviews Immunology.
[24] M. Perretti. Endogenous mediators that inhibit the leukocyte-endothelium interaction. , 1997, Trends in pharmacological sciences.
[25] P. Kivisäkk,et al. Jagged1 and Delta1 Differentially Regulate the Outcome of Experimental Autoimmune Encephalomyelitis1 , 2007, The Journal of Immunology.
[26] A. Ahluwalia,et al. Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse. A qualitative comparison with an anti-CD11b monoclonal antibody. , 1993, Journal of immunology.
[27] G. Haines,et al. Junctional adhesion molecule C mediates leukocyte adhesion to rheumatoid arthritis synovium. , 2008, Arthritis and rheumatism.
[28] C. Movitz,et al. Ligand recognition and activation of formyl peptide receptors in neutrophils , 2006, Journal of leukocyte biology.
[29] Justin Lamb,et al. The Connectivity Map: a new tool for biomedical research , 2007, Nature Reviews Cancer.
[30] E. Goetzl,et al. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network , 2005, Nature Reviews Immunology.
[31] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[32] G. Cagney,et al. Annexin-1 and Peptide Derivatives Are Released by Apoptotic Cells and Stimulate Phagocytosis of Apoptotic Neutrophils by Macrophages1 , 2007, The Journal of Immunology.
[33] A. Ohtsuka,et al. Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model. , 2008, Osteoarthritis and cartilage.
[34] V. Gerke,et al. A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. , 2000, Molecular cell.
[35] F. D’Acquisto,et al. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation , 2009, Nature Reviews Immunology.
[36] A. Kozikowski,et al. HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in rats , 2008, Brain Research.
[37] F. D’Acquisto,et al. Annexin‐A1: a pivotal regulator of the innate and adaptive immune systems , 2008, British journal of pharmacology.
[38] U. Rescher,et al. An Annexin 1 N-Terminal Peptide Activates Leukocytes by Triggering Different Members of the Formyl Peptide Receptor Family1 , 2004, The Journal of Immunology.
[39] P. Grieco,et al. Antimicrobial Properties of α-MSH and Related Synthetic Melanocortins , 2006, TheScientificWorldJournal.
[40] F. D’Acquisto,et al. Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation. , 2005, The American journal of pathology.
[41] M. Paul-Clark,et al. Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen-induced arthritis. , 2004, Arthritis and rheumatism.
[42] T. Golub,et al. Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance. , 2006, Cancer cell.
[43] A. Tosco,et al. Effects of FR235222, a novel HDAC inhibitor, in proliferation and apoptosis of human leukaemia cell lines: role of annexin A1. , 2008, European journal of cancer.
[44] D. Gilroy,et al. Inducible cyclooxygenase may have anti-inflammatory properties , 1999, Nature Medicine.